Creegan & Nassoura Financial Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $3.22M | Sell |
15,568
-487
| -3% | -$96.3K | 2.09% | 14 |
|
|
2025
Q3 | $2.98M | Sell |
16,055
-1,775
| -10% | -$304K | 1.92% | 18 |
|
|
2025
Q2 | $2.72M | Buy |
17,830
+1,115
| +7% | +$171K | 1.77% | 24 |
|
|
2025
Q1 | $2.77M | Hold |
16,715
| – | – | 1.85% | 21 |
|
|
2024
Q4 | $2.42M | Hold |
16,715
| – | – | 1.63% | 21 |
|
|
2024
Q3 | $2.71M | Sell |
16,715
-52
| -0.3% | -$8.29K | 1.71% | 23 |
|
|
2024
Q2 | $2.45M | Sell |
16,767
-200
| -1% | -$29.7K | 1.68% | 22 |
|
|
2024
Q1 | $2.68M | Buy |
16,967
+305
| +2% | +$48.5K | 1.79% | 20 |
|
|
2023
Q4 | $2.61M | Hold |
16,662
| – | – | 1.89% | 19 |
|
|
2023
Q3 | $2.6M | Sell |
16,662
-275
| -2% | -$45.4K | 2.02% | 15 |
|
|
2023
Q2 | $2.8M | Hold |
16,937
| – | – | 2.07% | 16 |
|
|
2023
Q1 | $2.63M | Hold |
16,937
| – | – | 2.01% | 17 |
|
|
2022
Q4 | $2.99M | Sell |
16,937
-5
| -0% | -$863 | 2.33% | 12 |
|
|
2022
Q3 | $2.77M | Sell |
16,942
-25
| -0.1% | -$4.23K | 2.4% | 10 |
|
|
2022
Q2 | $3.01M | Sell |
16,967
-84
| -0.5% | -$15K | 2.53% | 9 |
|
|
2022
Q1 | $3.02M | Buy |
17,051
+1
| +0% | +$170 | 2.27% | 14 |
|
|
2021
Q4 | $2.92M | Sell |
17,050
-208
| -1% | -$34.1K | 2.21% | 13 |
|
|
2021
Q3 | $2.79M | Buy |
17,258
+77
| +0.4% | +$13.1K | 2.38% | 11 |
|
|
2021
Q2 | $2.83M | Sell |
17,181
-698
| -4% | -$116K | 2.42% | 10 |
|
|
2021
Q1 | $2.94M | Sell |
17,879
-349
| -2% | -$56.5K | 2.62% | 9 |
|
|
2020
Q4 | $2.87M | Sell |
18,228
-99
| -0.5% | -$14.6K | 2.76% | 7 |
|
|
2020
Q3 | $2.73M | Sell |
18,327
-48
| -0.3% | -$7.1K | 2.94% | 5 |
|
|
2020
Q2 | $2.58M | Sell |
18,375
-100
| -0.5% | -$14.6K | 2.91% | 6 |
|
|
2020
Q1 | $2.42M | Sell |
18,475
-123
| -0.7% | -$17.5K | 3.16% | 6 |
|
|
2019
Q4 | $2.71M | Buy |
+18,598
| New | +$2.52M | 2.73% | 8 |
|
|
2016
Q3 | $2.91M | Sell |
24,654
-289
| -1% | -$35.1K | 3.4% | 3 |
|
|
2016
Q2 | $3.03M | Sell |
24,943
-173
| -0.7% | -$19.7K | 3.58% | 3 |
|
|
2016
Q1 | $2.72M | Sell |
25,116
-700
| -3% | -$72.5K | 3.22% | 4 |
|
|
2015
Q4 | $2.65M | Sell |
25,816
-37
| -0.1% | -$3.72K | 3.01% | 4 |
|
|
2015
Q3 | $2.41M | Sell |
25,853
-151
| -0.6% | -$14.6K | 2.75% | 5 |
|
|
2015
Q2 | $2.53M | Sell |
26,004
-98
| -0.4% | -$9.81K | 2.64% | 5 |
|
|
2015
Q1 | $2.63M | Sell |
26,102
-500
| -2% | -$50.8K | 2.7% | 5 |
|
|
2014
Q4 | $2.78M | Buy |
+26,602
| New | +$2.8M | 2.84% | 4 |
|
Other funds holding JNJ
Creegan & Nassoura Financial Group's JNJ Position: Q4 2025 in Review
Creegan & Nassoura Financial Group reduced its Johnson & Johnson (JNJ) stake by 3% in Q4 2025, selling an estimated $96.3K and leaving 15,568 shares worth $3.22M. The position accounts for 2.09% of the portfolio, ranked #14.
Creegan & Nassoura Financial Group first reported a position in JNJ in Q4 2014 and has held it in 33 quarters since. 4,521 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.
- Creegan & Nassoura Financial Group held 15,568 shares of Johnson & Johnson worth $3.22M as of Q4 2025.
- Creegan & Nassoura Financial Group sold 487 Johnson & Johnson shares in Q4 2025, an estimated $96.3K.
- Johnson & Johnson made up 2.09% of Creegan & Nassoura Financial Group's portfolio in Q4 2025, its #14 holding.
- Creegan & Nassoura Financial Group first reported a position in Johnson & Johnson in Q4 2014 and has held it in 33 quarters since.
- 4,521 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.
Based on Creegan & Nassoura Financial Group's 13F filing for Q4 2025, filed 17 Feb 2026.